Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
2.07
0.13 (6.70%)
At close: Aug 14, 2025, 3:59 PM
2.05
-0.97%
Pre-market: Aug 15, 2025, 09:24 AM EDT
Esperion Therapeutics Fail-to-Deliver
Total FTD Shares
326
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-98.3%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Esperion Therapeutics Inc. has
326
shares failed to deliver, representing 0.01%
of the average daily volume of
4,674,248
shares. Over the past year, the monthly average FTD is
48,017
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 1.18 | 326 | -97.03% |
Jun 24, 2025 | 1.07 | 10.96K | +21388.24% |
May 30, 2025 | 0.8498 | 51 | -85.39% |
Apr 29, 2025 | 0.9599 | 349 | -97.86% |
Mar 31, 2025 | 1.44 | 16.27K | -33.21% |
Feb 27, 2025 | 1.66 | 24.36K | -14.33% |
Jan 31, 2025 | 1.79 | 28.44K | +9379.00% |
Dec 30, 2024 | 2.15 | 300 | -99.92% |
Nov 29, 2024 | 2.8 | 373.87K | +23713.50% |
Oct 30, 2024 | 2.13 | 1.57K | -92.84% |
Sep 30, 2024 | 1.65 | 21.94K | +39.32% |
Aug 27, 2024 | 1.71 | 15.74K | +208.85% |
Jul 30, 2024 | 2.32 | 5.1K | -92.22% |
Jun 28, 2024 | 2.22 | 65.49K | +81763.75% |
May 31, 2024 | 2.16 | 80 | -99.91% |
Apr 30, 2024 | 1.97 | 89.75K | +3979.68% |
Mar 26, 2024 | 2.7 | 2.2K | -54.12% |
Feb 29, 2024 | 2.51 | 4.79K | +859.00% |
Jan 31, 2024 | 2.14 | 500 | -86.96% |
Dec 29, 2023 | 2.99 | 3.83K | -87.56% |
Nov 27, 2023 | 1.23 | 30.84K | +95.64% |
Oct 30, 2023 | 0.8263 | 15.76K | +77.81% |
Sep 28, 2023 | 0.958 | 8.86K | +15450.88% |
Aug 11, 2023 | 1.73 | 57 | -96.88% |
Jul 31, 2023 | 1.57 | 1.83K | +814.50% |
Jun 30, 2023 | 1.39 | 200 | -99.03% |
May 31, 2023 | 1.36 | 20.7K | -29.70% |
Apr 17, 2023 | 1.37 | 29.44K | +14921.94% |
Mar 30, 2023 | 1.67 | 196 | -90.75% |
Feb 28, 2023 | 6.18 | 2.12K | +2019.00% |
Jan 31, 2023 | 6.36 | 100 | n/a |